MRI-directed subthalamic nucleus surgery for Parkinson's disease

Area of Science:

• Neurosurgery
• Medical Imaging
• Neurology

Background:

• The subthalamic nucleus (STN) is a key surgical target for Parkinson's disease.
• Medically refractory Parkinson's disease often requires advanced interventions.
• Accurate targeting is crucial for effective and safe neurosurgical procedures.

Purpose of the Study:

• To evaluate the accuracy and efficacy of a predominantly MRI-directed targeting method for the subthalamic nucleus (STN).
• To assess the feasibility of performing STN targeting and procedures under general anesthesia using MRI guidance.

Main Methods:

• Localization of the STN using high-resolution T2-weighted MRI scans (1.5-T) in axial and coronal planes.
• Co-registration of STN boundaries for precise 3D target definition and trajectory planning.
• Intraoperative verification using MRI to assess target accuracy, with a mean error of 0.3-0.4 mm.

Main Results:

• Successful lesion localization within the dorsolateral STN in 21 patients undergoing subthalamotomy.
• Mean targeting error of 0.3 mm mediolaterally and 0.4 mm anteroposteriorly in 37 STN targetings for deep brain stimulation (DBS).
• Over 90% of planned DBS electrode trajectories were within 0.5 mm of the target.

Conclusions:

• MRI-directed targeting of the STN is highly accurate and reliable for both subthalamotomy and DBS.
• This method allows for direct intraoperative verification and correction, enhancing surgical precision.
• The technique's accuracy and ability to be performed under general anesthesia offer advantages over traditional methods.